 Whitney Jackson
Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 19 | 2023 | 707 | 4.070 |
Why?
| | Living Donors | 15 | 2023 | 270 | 2.070 |
Why?
| | End Stage Liver Disease | 3 | 2023 | 63 | 1.740 |
Why?
| | Tissue and Organ Procurement | 6 | 2023 | 228 | 1.380 |
Why?
| | Sofosbuvir | 2 | 2017 | 54 | 1.060 |
Why?
| | Hepacivirus | 2 | 2017 | 229 | 0.960 |
Why?
| | Kidney Transplantation | 4 | 2023 | 541 | 0.890 |
Why?
| | Antiviral Agents | 2 | 2017 | 645 | 0.740 |
Why?
| | Fatty Liver | 1 | 2023 | 211 | 0.710 |
Why?
| | Liver Diseases | 1 | 2023 | 255 | 0.690 |
Why?
| | Ribavirin | 2 | 2017 | 89 | 0.630 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 16 | 0.570 |
Why?
| | Carbamates | 1 | 2017 | 34 | 0.560 |
Why?
| | Simeprevir | 1 | 2016 | 8 | 0.530 |
Why?
| | Hepatitis C, Chronic | 1 | 2017 | 151 | 0.490 |
Why?
| | Tuberculosis, Hepatic | 1 | 2014 | 2 | 0.470 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2014 | 39 | 0.460 |
Why?
| | Liver | 10 | 2023 | 1637 | 0.460 |
Why?
| | Hepatitis | 1 | 2014 | 45 | 0.460 |
Why?
| | Hepatitis C | 1 | 2016 | 219 | 0.430 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2014 | 112 | 0.430 |
Why?
| | Emigrants and Immigrants | 1 | 2014 | 107 | 0.400 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 268 | 0.380 |
Why?
| | Graft Survival | 5 | 2023 | 446 | 0.350 |
Why?
| | Weight Loss | 1 | 2014 | 642 | 0.340 |
Why?
| | Retrospective Studies | 9 | 2023 | 12551 | 0.320 |
Why?
| | United States | 8 | 2023 | 12183 | 0.240 |
Why?
| | Humans | 22 | 2023 | 114689 | 0.230 |
Why?
| | Treatment Outcome | 4 | 2023 | 9088 | 0.230 |
Why?
| | Solitary Kidney | 1 | 2023 | 7 | 0.220 |
Why?
| | Transplant Recipients | 2 | 2023 | 140 | 0.200 |
Why?
| | Sodium | 1 | 2022 | 183 | 0.190 |
Why?
| | Genotype | 2 | 2017 | 1760 | 0.190 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 8 | 0.170 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 12 | 0.170 |
Why?
| | Toxoplasmosis | 1 | 2019 | 31 | 0.170 |
Why?
| | Nephrectomy | 1 | 2020 | 150 | 0.160 |
Why?
| | Severity of Illness Index | 2 | 2023 | 2540 | 0.150 |
Why?
| | Biliary Atresia | 1 | 2020 | 185 | 0.150 |
Why?
| | Premature Birth | 1 | 2021 | 276 | 0.150 |
Why?
| | Lung Transplantation | 1 | 2019 | 246 | 0.140 |
Why?
| | Tissue Donors | 1 | 2019 | 316 | 0.140 |
Why?
| | Sustained Virologic Response | 1 | 2017 | 33 | 0.140 |
Why?
| | Drug Resistance, Viral | 1 | 2017 | 99 | 0.130 |
Why?
| | Drug Combinations | 1 | 2017 | 287 | 0.130 |
Why?
| | Drug Interactions | 1 | 2017 | 338 | 0.130 |
Why?
| | Case-Control Studies | 1 | 2022 | 3003 | 0.130 |
Why?
| | Viral Load | 1 | 2017 | 405 | 0.120 |
Why?
| | Vietnam | 1 | 2014 | 21 | 0.120 |
Why?
| | Mitochondria | 1 | 2020 | 747 | 0.120 |
Why?
| | Ohio | 1 | 2014 | 135 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2014 | 103 | 0.110 |
Why?
| | Risk Assessment | 1 | 2022 | 2968 | 0.110 |
Why?
| | Recurrence | 1 | 2016 | 935 | 0.110 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 951 | 0.110 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 932 | 0.100 |
Why?
| | Male | 6 | 2022 | 55599 | 0.100 |
Why?
| | Waiting Lists | 2 | 2023 | 211 | 0.090 |
Why?
| | Female | 7 | 2022 | 59511 | 0.090 |
Why?
| | Biopsy | 1 | 2014 | 1036 | 0.090 |
Why?
| | Quality of Life | 1 | 2020 | 2353 | 0.080 |
Why?
| | Middle Aged | 4 | 2020 | 26737 | 0.080 |
Why?
| | Child | 3 | 2022 | 18415 | 0.080 |
Why?
| | Adult | 4 | 2023 | 30550 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2286 | 0.060 |
Why?
| | Young Adult | 2 | 2019 | 10470 | 0.060 |
Why?
| | Prospective Studies | 1 | 2016 | 6220 | 0.060 |
Why?
| | Risk Factors | 1 | 2017 | 8632 | 0.060 |
Why?
| | Donor Selection | 1 | 2023 | 66 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 17848 | 0.050 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 4623 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 537 | 0.040 |
Why?
| | Preoperative Care | 1 | 2022 | 319 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 58 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 23 | 0.040 |
Why?
| | Remission Induction | 1 | 2020 | 233 | 0.040 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2019 | 39 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 88 | 0.040 |
Why?
| | Pregnancy Outcome | 1 | 2021 | 337 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 120 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 284 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1214 | 0.040 |
Why?
| | Infant | 2 | 2020 | 7963 | 0.040 |
Why?
| | Pain | 1 | 2022 | 705 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1188 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 3329 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 520 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4411 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5047 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 5518 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3053 | 0.020 |
Why?
|
|
Jackson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|